167:
in 1982 before returning to the
University of Washington to serve as chief resident and pursue a fellowship in oncology. In 1986, he joined as faculty at the University of Washington, where he eventually became a professor of medicine and adjunct professor of bioengineering, and as a member of the
217:
In addition to his clinical service and research achievements, Press was well-regarded as a mentor. He directly trained more than 70 physicians and scientists over the course of his career, and served as associate director of the
University of Washington Medical Scientist Training program from
576:
Rufener, Gregory A.; Press, Oliver W.; Olsen, Philip; Lee, Sang Yun; Jensen, Michael C.; Gopal, Ajay K.; Pender, Barbara; Budde, Lihua E.; Rossow, Jeffrey K.; Green, Damian J.; Maloney, David G.; Riddell, Stanley R.; Till, Brian G. (June 2016).
151:, Missouri. Press described being passionate about zoology as a child, and frequently captured snakes and frogs from the parks near his home. After majoring in biology at
175:
Press met his future wife, Nancy, through a study-abroad program as an undergraduate. Nancy worked in Press's lab and oversaw administrative work throughout his career.
352:
233:
Gold Award for
Achievement in Medical Research from Seattle Business Magazine; and several awards from the Lymphoma Research Foundation, including the organization's
210:. Throughout his career, Press continued to advance and refine such therapies in order to increase their clinical usage, including the early application of
94:
634:
690:
680:
155:, Press decided to study medicine, both as a means to apply the study of biology to help people and as a means to secure draft deferment from the
675:
685:
160:
33:
388:
112:
169:
203:
195:
501:
Press, O. W.; Appelbaum, F.; Ledbetter, J. A.; Martin, P. J.; Zarling, J.; Kidd, P.; Thomas, E. D. (February 1987).
551:
290:
273:
139:. Press was best known for his contributions to the development of targeted cancer therapies for blood cancers.
579:"Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab"
116:
89:
239:
SAAS Foundation for
Medical Research's John Ultmann Award for Contributions to Lymphoma Research (posthumous)
230:
Research
Visionary Champion Award from the Washington/Alaska chapter of the Leukemia & Lymphoma Society
475:
164:
670:
665:
207:
152:
84:
72:
53:
315:
199:
353:"Leading Lymphoma Clinician, Researcher, and Mentor, Oliver 'Ollie' Press, MD, PhD, Dies at 65"
616:
598:
530:
522:
606:
590:
514:
445:
420:
611:
578:
159:. Press earned both a medical doctorate and PhD through the University of Washington
659:
594:
518:
156:
183:
Press conducted translational research to develop more effective therapies for
211:
602:
526:
198:
for lymphoma. He was instrumental in the subsequent development of lymphoma
148:
136:
620:
503:"Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas"
502:
425:
408:
316:"Lymphoma Research Foundation Statement On the Passing of Dr. Oliver Press"
32:
534:
191:
184:
132:
389:"'He transformed my life': A cancer doctor's work comes full circle"
188:
242:
American
Society of Hematology's 2017 Mentor Award (posthumous)
635:"Letter From the Editor: In Memory of Oliver Press, MD, PhD"
245:
Excellence in
Mentorship Award, UW Department of Medicine
131:(September 10, 1952 – September 29, 2017) was an American
236:
Distinguished
Service Award, Lymphoma Research Foundation
446:"Remembering Ollie Press | Department of Medicine News"
108:
80:
61:
39:
23:
227:Oliver W. Press Distinguished MSTP Alumnus Award
556:American Association for Cancer Research (AACR)
476:"Mourning the Loss of Dr. Oliver 'Ollie' Press"
295:American Association for Cancer Research (AACR)
274:"Mourning the loss of Dr. Oliver 'Ollie' Press"
163:. Press completed internship and residency at
8:
95:University of Washington School of Medicine
31:
20:
610:
424:
260:
409:"Oliver W. Press, MD, PhD (1952-2017)"
16:American cancer researcher (1952–2017)
546:
544:
214:cells for the treatment of lymphoma.
170:Fred Hutchison Cancer Research Center
113:Fred Hutchison Cancer Research Center
7:
470:
468:
466:
440:
438:
436:
402:
400:
398:
383:
381:
379:
377:
375:
373:
346:
344:
342:
340:
338:
336:
285:
283:
268:
266:
264:
187:. Press pioneered the use of anti-
161:Medical Scientist Training Program
14:
351:Piana, Ronald (25 October 2017).
691:University of Washington faculty
681:University of Washington alumni
1:
595:10.1158/2326-6066.CIR-15-0276
320:Lymphoma Research Foundation
519:10.1182/blood.V69.2.584.584
196:monoclonal antibody therapy
707:
676:Stanford University alumni
583:Cancer Immunology Research
686:Physicians from St. Louis
639:hematologyandoncology.net
122:
101:
30:
117:University of Washington
90:University of Washington
407:Pagel, John M. (2018).
129:Oliver "Ollie" W. Press
426:10.1182/hem.V15.1.8192
165:Mass General Hospital
208:Ibritumomab tiuxetan
153:Stanford University
85:Stanford University
73:Seattle, Washington
54:St. Louis, Missouri
200:radioimmunotherapy
147:Press was born in
65:September 29, 2017
50:September 10, 1952
552:"Oliver W. Press"
291:"Oliver W. Press"
202:and the eventual
126:
125:
103:Scientific career
698:
650:
649:
647:
645:
631:
625:
624:
614:
573:
567:
566:
564:
562:
548:
539:
538:
498:
492:
491:
489:
487:
482:. 8 October 2017
472:
461:
460:
458:
456:
442:
431:
430:
428:
413:The Hematologist
404:
393:
392:
385:
368:
367:
365:
363:
348:
331:
330:
328:
326:
312:
306:
305:
303:
301:
287:
278:
277:
270:
68:
49:
47:
35:
21:
706:
705:
701:
700:
699:
697:
696:
695:
656:
655:
654:
653:
643:
641:
633:
632:
628:
575:
574:
570:
560:
558:
550:
549:
542:
500:
499:
495:
485:
483:
474:
473:
464:
454:
452:
444:
443:
434:
406:
405:
396:
387:
386:
371:
361:
359:
350:
349:
334:
324:
322:
314:
313:
309:
299:
297:
289:
288:
281:
272:
271:
262:
257:
224:
181:
145:
135:researcher and
115:
93:
88:
81:Alma mater
76:
70:
66:
57:
56:, United States
51:
45:
43:
26:
17:
12:
11:
5:
704:
702:
694:
693:
688:
683:
678:
673:
668:
658:
657:
652:
651:
626:
589:(6): 509–519.
568:
540:
513:(2): 584–591.
493:
462:
450:mednews.uw.edu
432:
394:
369:
332:
307:
279:
259:
258:
256:
253:
252:
251:
250:
249:
243:
240:
237:
234:
231:
228:
223:
220:
180:
177:
144:
141:
124:
123:
120:
119:
110:
106:
105:
99:
98:
82:
78:
77:
71:
69:(aged 65)
63:
59:
58:
52:
41:
37:
36:
28:
27:
24:
15:
13:
10:
9:
6:
4:
3:
2:
703:
692:
689:
687:
684:
682:
679:
677:
674:
672:
669:
667:
664:
663:
661:
640:
636:
630:
627:
622:
618:
613:
608:
604:
600:
596:
592:
588:
584:
580:
572:
569:
557:
553:
547:
545:
541:
536:
532:
528:
524:
520:
516:
512:
508:
504:
497:
494:
481:
477:
471:
469:
467:
463:
451:
447:
441:
439:
437:
433:
427:
422:
418:
414:
410:
403:
401:
399:
395:
390:
384:
382:
380:
378:
376:
374:
370:
358:
357:The ASCO Post
354:
347:
345:
343:
341:
339:
337:
333:
321:
317:
311:
308:
296:
292:
286:
284:
280:
275:
269:
267:
265:
261:
254:
247:
246:
244:
241:
238:
235:
232:
229:
226:
225:
221:
219:
215:
213:
209:
205:
201:
197:
193:
190:
186:
178:
176:
173:
171:
166:
162:
158:
154:
150:
142:
140:
138:
134:
130:
121:
118:
114:
111:
107:
104:
100:
96:
91:
86:
83:
79:
74:
64:
60:
55:
42:
38:
34:
29:
22:
19:
642:. Retrieved
638:
629:
586:
582:
571:
559:. Retrieved
555:
510:
506:
496:
484:. Retrieved
479:
453:. Retrieved
449:
416:
412:
360:. Retrieved
356:
323:. Retrieved
319:
310:
298:. Retrieved
294:
216:
206:approval of
182:
174:
146:
128:
127:
109:Institutions
102:
67:(2017-09-29)
25:Oliver Press
18:
671:2017 deaths
666:1952 births
644:24 February
561:26 February
486:24 February
455:24 February
362:24 February
325:24 February
300:24 February
218:2014-2017.
157:Vietnam War
660:Categories
255:References
192:antibodies
92:(PhD,1977)
87:(BS, 1973)
46:1952-09-10
603:2326-6074
527:0006-4971
149:St. Louis
143:Biography
137:physician
97:(MD,1979)
621:27197068
248:Sources:
185:lymphoma
612:4891234
535:3492224
480:OncLive
619:
609:
601:
533:
525:
222:Awards
179:Career
133:cancer
507:Blood
212:CAR T
194:as a
646:2024
617:PMID
599:ISSN
563:2024
531:PMID
523:ISSN
488:2024
457:2024
364:2024
327:2024
302:2024
189:CD20
75:, US
62:Died
40:Born
607:PMC
591:doi
515:doi
421:doi
204:FDA
662::
637:.
615:.
605:.
597:.
585:.
581:.
554:.
543:^
529:.
521:.
511:69
509:.
505:.
478:.
465:^
448:.
435:^
419:.
417:15
415:.
411:.
397:^
372:^
355:.
335:^
318:.
293:.
282:^
263:^
172:.
648:.
623:.
593::
587:4
565:.
537:.
517::
490:.
459:.
429:.
423::
391:.
366:.
329:.
304:.
276:.
48:)
44:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
